Education
About Us
Working with TipRanks
Follow Us
Tissue Regenix (GB:TRX)
:TRX
TRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range25.00p - 67.00p
Previous CloseN/A
Volume536.00
Average Volume (3M)111.02K
Market Cap
£26.36M
Enterprise Value33.41M
Total Cash (Recent Filing)£3.46M
Total Debt (Recent Filing)$10.47M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Sep 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding71,395,640
10 Day Avg. Volume87,234
30 Day Avg. Volume111,017
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio-4.35
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit2.70
Enterprise Value/Ebitda41.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tissue Regenix News
PremiumCompany Announcements
Tissue Regenix Secures Strong Shareholder Support at AGM
PremiumCompany Announcements
Tissue Regenix Awards Share Options to Executives
PremiumCompany Announcements
Tissue Regenix Announces AGM and Investor Briefing
PremiumCompany Announcements
Tissue Regenix Achieves Record Growth and Profitability in 2024
PremiumCompany Announcements
Tissue Regenix Concludes Strategic Review, Focuses on Independent Growth
PremiumCompany Announcements
Tissue Regenix Secures European Patent for dCELL® Technology
PremiumCompany Announcements
Tissue Regenix Reports Strong 2024 Performance and Strategic DivestmentOptions Prices
Currently, No data available
---
Ownership Overview
0.77% Insiders
―
Mutual Funds
― Other Institutional Investors
99.23% Public Companies and
Individual Investors
TRX FAQ
What was Tissue Regenix’s price range in the past 12 months?
Tissue Regenix lowest share price was 25.00p and its highest was 67.00p in the past 12 months.
What is Tissue Regenix’s market cap?
Tissue Regenix’s market cap is £26.36M.
When is Tissue Regenix’s upcoming earnings report date?
Tissue Regenix’s upcoming earnings report date is Sep 03, 2025 which is in 35 days.
How were Tissue Regenix’s earnings last quarter?
Tissue Regenix released its earnings results on Jun 25, 2025. The company reported -0.005p earnings per share for the quarter, missing the consensus estimate of 0p by -0.005p.
Is Tissue Regenix overvalued?
According to Wall Street analysts Tissue Regenix’s price is currently Overvalued.
Does Tissue Regenix pay dividends?
Tissue Regenix does not currently pay dividends.
What is Tissue Regenix’s EPS estimate?
Tissue Regenix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tissue Regenix have?
Tissue Regenix has 71,395,640 shares outstanding.
What happened to Tissue Regenix’s price movement after its last earnings report?
Tissue Regenix reported an EPS of -0.005p in its last earnings report, missing expectations of 0p. Following the earnings report the stock price went up 1.639%.
Which hedge fund is a major shareholder of Tissue Regenix?
Currently, no hedge funds are holding shares in GB:TRX
Tissue Regenix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.98%
12-Months-Change
Fundamentals
Return on Equity
-2.91%
Trailing 12-Months
Asset Growth
6.74%
Trailing 12-Months
Company Description
Tissue Regenix
Tissue Regenix (TRX) is a pioneering medical technology company that operates in the field of regenerative medicine. The company focuses on the development and commercialization of advanced tissue-based solutions, utilizing its proprietary decellularization technology. Tissue Regenix provides innovative products for wound care, orthopedic, and dental applications, helping to improve patient outcomes and quality of life.